Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody (Q45419865)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody |
scientific article |
Statements
1 reference
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody (English)
1 reference
Paul J Kostenuik
1 reference
Susan Y Smith
1 reference
Jacquelin Jolette
1 reference
Joseph Schroeder
1 reference
Ian Pyrah
1 reference
Michael S Ominsky
1 reference
30 March 2011
1 reference
1 reference
49
1 reference
2
1 reference
151-161
1 reference
Identifiers
1 reference
1 reference